| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |